Article
Whole genome sequencing distinguishes between relapse and reinfection in recurrent leprosy cases
15 Jun 2017
Abstract excerpt
BACKGROUND: Since leprosy is both treated and controlled by multidrug therapy (MDT) it is important to monitor recurrent cases for drug resistance and to distinguish between relapse and reinfection as a means of assessing therapeutic efficacy. All three objectives can be reached with single nucleotide resolution using next generation sequencing and bioinformatics analysis of Mycobacterium leprae DNA present in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
